Tilton's Zohar III Should Be Run by Trustee, U.S. Tells Judge
(Bloomberg) -- Lynn Tilton's bankrupt investment vehicle, Zohar III, should be taken over by a trustee because of the “debilitating and entrenched acrimony” between Tilton and Zohar's creditors, a government watchdog that monitors corporate bankruptcies said in a court filing Tuesday.
The U.S. Trustee, an arm of the Department of Justice, also cited Tilton's “apparent conflicts of interest” and asked the judge overseeing Zohar's bankruptcy to either install a trustee to run the company, or to appoint an examiner to investigate the funds.
Tilton put Zohar III into bankruptcy last month to resolve lawsuits involving the structured debt vehicles she used to finance distressed companies. The acrimony between Zohar III and its creditors, including MBIA Insurance Corp. and Alvarez & Marsal Zohar Management LLC, is disrupting the bankruptcy case, Brya Keilson, a trial attorney with the U.S. Trustee's Office, said in court papers.
So far in the bankruptcy, Tilton “has exhibited a lack of diligence and an inability to fulfill the fiduciary duties imposed on management of a chapter 11 debtor-in-possession,” Keilson said.
Zohar attorney Michael Nestor and Tilton attorney Robert Klyman did not immediately return calls requesting comment.
The bankruptcy case is Zohar III Corp., 18-10512, U.S. Bankruptcy Court, District of Delaware (Delaware.)
To contact the reporter on this story: Steven Church in Wilmington, Delaware at schurch3@bloomberg.net.
To contact the editors responsible for this story: Nikolaj Gammeltoft at ngammeltoft@bloomberg.net, Dan Wilchins, Sally Bakewell
©2018 Bloomberg L.P.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.